P
68.05
0.79 (1.17%)
| 前收盘价格 | 67.26 |
| 收盘价格 | 67.54 |
| 成交量 | 128,941 |
| 平均成交量 (3个月) | 458,601 |
| 市值 | 3,349,026,560 |
| 市盈率 (P/E TTM) | 15.97 |
| 预期市盈率 (P/E Forward) | 14.33 |
| 价格/销量 (P/S) | 2.90 |
| 股市价格/股市净资产 (P/B) | 1.72 |
| 52周波幅 | |
| 利润日期 | 6 Nov 2025 |
| 营业毛利率 | 18.86% |
| 营业利益率 (TTM) | 34.03% |
| 稀释每股收益 (EPS TTM) | 4.29 |
| 季度收入增长率 (YOY) | 7.10% |
| 季度盈利增长率 (YOY) | 1.40% |
| 总债务/股东权益 (D/E MRQ) | 56.91% |
| 流动比率 (MRQ) | 4.20 |
| 营业现金流 (OCF TTM) | 251.52 M |
| 杠杆自由现金流 (LFCF TTM) | 188.69 M |
| 资产报酬率 (ROA TTM) | 6.50% |
| 股东权益报酬率 (ROE TTM) | 12.30% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 看涨 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 看涨 | 混合的 | |
| 股票 | Prestige Consumer Healthcare In | 看涨 | 看涨 |
AIStockmoo 评分
1.9
| 分析师共识 | 3.5 |
| 内部交易活动 | NA |
| 价格波动 | 4.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.88 |
|
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Core |
| 内部持股比例 | 1.23% |
| 机构持股比例 | 108.15% |
| 52周波幅 | ||
| 中 | 100.00 (46.95%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Canaccord Genuity | 08 Aug 2025 | 100.00 (46.95%) | 购买 | 65.58 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合